Abstract
Given the publication by ANVISA of RDC430/2021 in the midst of the global pandemic scenario, Brazil is in line with the international directives of the World Health Organization (WHO) and the FDA, with regard to the Cold Chain (logistics chain of vaccines, blood products and drugs from manufacture to point of use).Within what the international norms and the aforementioned RDC recommend, t…